Are you passionate about applying your scientific skills in preclinical research? Would you like to deepen your knowledge within formulation of drug candidates across various modalities? Then this might be the right opportunity for you!
About the role
Gubra is expanding and looking for a Scientist to join our Formulation department. You will work with formulation of drug candidates for in vivo pharmacology studies, supporting both internal and partnered drug discovery projects as well as our Contract Research Organization (CRO) services.
The Formulation department plays a key role in supporting Gubra’s research by preparing formulations of drug candidates (peptides, antibodies, small molecules, etc.) for use in preclinical rodent and minipig models across metabolic and fibrotic disease areas.
The team also supports the preparation of model inducers and provides scientific input to Sales, Projects and Pharmacology teams on reference compounds, formulation vehicles, and procedures.
You will join a dedicated team of 2 Scientists and 8 Laboratory Technicians who work closely together and collaborate across departments at Gubra.
Your key responsibilities
As our new Formulation Scientist, you will:
Your qualifications
We imagine that you have:
Who you are
Please apply no later than November 11, 2025 by uploading your motivated cover letter and resume on our website. We will be reviewing applications and inviting relevant candidates for interviews on an ongoing basis. For questions about the position, please contact Lene Arildsen, Department Manager of Formulation, at lea@gubra.dk.
About Gubra
Gubra is an ambitious biotech and contract research organisation (CRO) company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the path towards a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.
Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: Biotech and CRO Services. We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.
Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.
People are our greatest asset, and our team consists of +280 employees all located in Hørsholm, Denmark. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!